CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
EPA:CLARI - Euronext Paris - Matif - FR0010386334 - Common Stock - Currency: EUR
We assign a fundamental rating of 2 out of 10 to CLARI. CLARI was compared to 24 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CLARI has reported negative net income.
CLARI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
In the past 5 years CLARI always reported a positive cash flow from operatings.
1.2 Ratios
CLARI's Return On Assets of -0.39% is on the low side compared to the rest of the industry. CLARI is outperformed by 79.17% of its industry peers.
The Return On Equity of CLARI (-1.49%) is worse than 79.17% of its industry peers.
With a Return On Invested Capital value of 1.86%, CLARI is not doing good in the industry: 70.83% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for CLARI is below the industry average of 6.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROIC | 1.86% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
CLARI has a Operating Margin (5.44%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CLARI has declined.
The Gross Margin of CLARI (91.68%) is better than 95.83% of its industry peers.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
CLARI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CLARI has been increased compared to 1 year ago.
Compared to 5 years ago, CLARI has more shares outstanding
The debt/assets ratio for CLARI has been reduced compared to a year ago.
2.2 Solvency
CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLARI (0.62) is worse than 70.83% of its industry peers.
The Debt to FCF ratio of CLARI is 13.44, which is on the high side as it means it would take CLARI, 13.44 years of fcf income to pay off all of its debts.
CLARI's Debt to FCF ratio of 13.44 is on the low side compared to the rest of the industry. CLARI is outperformed by 62.50% of its industry peers.
CLARI has a Debt/Equity ratio of 1.78. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CLARI (1.78) is worse than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.46
WACC4.06%
2.3 Liquidity
CLARI has a Current Ratio of 0.56. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI's Current ratio of 0.56 is on the low side compared to the rest of the industry. CLARI is outperformed by 87.50% of its industry peers.
CLARI has a Quick Ratio of 0.56. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI's Quick ratio of 0.56 is on the low side compared to the rest of the industry. CLARI is outperformed by 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.18% over the past year.
Looking at the last year, CLARI shows a small growth in Revenue. The Revenue has grown by 5.73% in the last year.
CLARI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.89% yearly.
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
3.2 Future
CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.62% yearly.
The Revenue is expected to grow by 4.63% on average over the next years.
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y4.33%
Revenue Next 3Y4.63%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 26.11, which means the current valuation is very expensive for CLARI.
CLARI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CLARI is more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, CLARI is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 26.11 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CLARI.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.2 | ||
| EV/EBITDA | 8.85 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLARI's earnings are expected to grow with 64.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.37%
EPS Next 3Y64.62%
5. Dividend
5.1 Amount
CLARI has a Yearly Dividend Yield of 10.64%, which is a nice return.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 2.77. CLARI pays more dividend than 100.00% of the companies in the same industry.
CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-92.12%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPA:CLARI (5/22/2025, 7:00:00 PM)
3.658
-0.09 (-2.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners41.38%
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap1.30B
Analysts45.45
Price Target2.79 (-23.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-92.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.2%
PT rev (3m)52.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)70%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 26.11 | ||
| P/S | 0.25 | ||
| P/FCF | 2.2 | ||
| P/OCF | 1.45 | ||
| P/B | 0.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.85 |
EPS(TTM)-0.47
EYN/A
EPS(NY)0.14
Fwd EY3.83%
FCF(TTM)1.66
FCFY45.46%
OCF(TTM)2.53
OCFY69.11%
SpS14.84
BVpS10.37
TBVpS-5.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROCE | 2.53% | ||
| ROIC | 1.86% | ||
| ROICexc | 1.95% | ||
| ROICexgc | 4.01% | ||
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% | ||
| FCFM | 11.21% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Debt/EBITDA | 6.65 | ||
| Cap/Depr | 43.77% | ||
| Cap/Sales | 5.83% | ||
| Interest Coverage | 0.96 | ||
| Cash Conversion | 90.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 0.62 |
F-Score5
WACC4.06%
ROIC/WACC0.46
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
Revenue Next Year3.9%
Revenue Next 2Y4.33%
Revenue Next 3Y4.63%
Revenue Next 5YN/A
EBIT growth 1Y-8.92%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year311.97%
EBIT Next 3Y70.36%
EBIT Next 5YN/A
FCF growth 1Y85%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.93%
OCF growth 3Y2.33%
OCF growth 5Y3.29%